Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 25 11:16AM ET
25.55
Dollar change
-0.72
Percentage change
-2.73
%
IndexS&P 500 P/E71.10 EPS (ttm)0.36 Insider Own0.04% Shs Outstand5.65B Perf Week0.64%
Market Cap144.29B Forward P/E9.34 EPS next Y2.73 Insider Trans0.13% Shs Float5.64B Perf Month-7.38%
Income2.13B PEG- EPS next Q0.53 Inst Own70.10% Short Float1.21% Perf Quarter-6.98%
Sales58.50B P/S2.47 EPS this Y20.03% Inst Trans0.52% Short Ratio1.61 Perf Half Y-16.03%
Book/sh15.77 P/B1.62 EPS next Y23.81% ROA1.01% Short Interest68.06M Perf Year-35.03%
Cash/sh2.25 P/C11.37 EPS next 5Y-1.33% ROE2.31% 52W Range25.23 - 40.37 Perf YTD-11.24%
Dividend Est.1.70 (6.65%) P/FCF30.10 EPS past 5Y-27.43% ROI1.39% 52W High-36.70% Beta0.61
Dividend TTM1.65 (6.46%) Quick Ratio0.69 Sales past 5Y10.96% Gross Margin48.99% 52W Low1.28% ATR (14)0.49
Dividend Ex-DateJan 25, 2024 Current Ratio0.91 EPS Y/Y TTM-93.20% Oper. Margin6.16% RSI (14)35.70 Volatility1.58% 1.61%
Employees88000 Debt/Eq0.84 Sales Y/Y TTM-41.70% Profit Margin3.65% Recom2.32 Target Price31.22
Option/ShortYes / Yes LT Debt/Eq0.72 EPS Q/Q-168.11% Payout439.41% Rel Volume1.02 Prev Close26.27
Sales Surprise-0.84% EPS Surprise163.21% Sales Q/Q-41.34% EarningsMay 01 BMO Avg Volume42.31M Price25.55
SMA20-3.66% SMA50-5.46% SMA200-16.49% Trades Volume13,364,690 Change-2.73%
Date Action Analyst Rating Change Price Target Change
Mar-22-24Downgrade Argus Buy → Hold
Feb-23-24Initiated Guggenheim Buy $36
Jan-04-24Downgrade TD Cowen Outperform → Market Perform $32
Oct-20-23Resumed UBS Neutral $36 → $34
Oct-16-23Upgrade Jefferies Hold → Buy $38 → $39
Jul-17-23Reiterated JP Morgan Neutral $45 → $41
Jul-14-23Initiated HSBC Securities Buy $50
Jun-29-23Downgrade Credit Suisse Outperform → Neutral $47 → $40
May-11-23Downgrade Daiwa Securities Outperform → Neutral $38
Mar-06-23Initiated Jefferies Hold $43
Today 09:54AM
09:39AM
09:20AM
02:26AM
Apr-24-24 04:37PM
02:45PM Loading…
02:45PM
11:31AM
10:01AM
08:41AM
04:01AM
Apr-23-24 09:15AM
07:21AM
Apr-22-24 06:08PM
05:45PM
11:10AM
08:08AM Loading…
08:08AM
Apr-21-24 10:43AM
10:39AM
Apr-20-24 05:50AM
Apr-19-24 02:05PM
09:00AM
Apr-18-24 09:54AM
09:15AM
Apr-17-24 06:39AM
06:00AM
05:21AM
Apr-16-24 11:36PM
01:49PM
05:05AM
Apr-15-24 05:45PM
08:45AM Loading…
08:45AM
04:53AM
Apr-14-24 03:00PM
03:00AM
Apr-13-24 12:18PM
10:00AM
05:47AM
Apr-12-24 06:30PM
06:07AM
05:50AM
05:00AM
Apr-11-24 10:00AM
09:53AM
09:12AM
Apr-10-24 03:30PM
12:47PM
09:26AM
02:06AM
Apr-09-24 05:14PM
12:49PM
10:54AM
08:15AM
08:10AM
07:02AM
06:47AM
06:45AM
05:50AM
Apr-08-24 05:57PM
05:45PM
12:44PM
09:00AM
05:47AM
05:06AM
Apr-07-24 05:47AM
Apr-06-24 06:49AM
Apr-05-24 02:16PM
06:12AM
Apr-04-24 09:27AM
04:05AM
Apr-02-24 10:22AM
05:21AM
Apr-01-24 05:45PM
02:49PM
10:15AM
07:56AM
05:05AM
Mar-31-24 09:31AM
Mar-30-24 03:52PM
Mar-29-24 11:04PM
Mar-28-24 07:03PM
05:28PM
02:36PM
01:38PM
10:06AM
Mar-27-24 09:25AM
09:00AM
08:20AM
04:50AM
Mar-26-24 05:12PM
02:47PM
08:36AM
06:18AM
06:18AM
04:17AM
Mar-25-24 05:45PM
09:48AM
06:47AM
06:25AM
05:51AM
04:50AM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOURLA ALBERTChairman & CEOFeb 23 '24Option Exercise27.34127,6743,490,607439,748Feb 27 01:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23 '24Option Exercise27.3495,7552,617,942230,920Feb 27 01:46 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23 '24Option Exercise27.3463,8371,745,304218,148Feb 27 01:46 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23 '24Option Exercise27.3429,436804,780123,073Feb 27 01:46 PM
McDermott MichaelExecutive Vice PresidentFeb 23 '24Option Exercise27.3412,412339,34495,408Feb 27 01:47 PM
SAHNI PAYALExecutive Vice PresidentFeb 23 '24Option Exercise27.3411,527315,14834,604Feb 27 01:46 PM
DAMICO JENNIFER B.SVP & ControllerFeb 23 '24Option Exercise27.349,752266,62019,228Feb 27 01:46 PM
BOSHOFF CHRISTOFFELExecutive Vice PresidentFeb 23 '24Option Exercise27.349,752266,620148,703Feb 27 01:44 PM
Gottlieb ScottDirectorDec 15 '23Buy26.473,00079,4019,000Dec 19 09:31 AM
Gottlieb ScottDirectorMay 08 '23Buy38.581,00038,5806,000May 09 04:17 PM
Gottlieb ScottDirectorMay 05 '23Buy38.421,00038,4255,000May 09 04:17 PM